Latest Japan Approvals Include Evrysdi For SMA

Plus Global First For Imeglimin

 
• By Ian Haydock

Japan's latest batch of product approvals includes the country's second therapy for SMA and the first nod globally for a novel antidiabetic.

migraine
Two New Migraine Drugs Approved In Japan • Source: Alamy

More from Japan

More from Asia